FDA Notices of Judgment Collection, 1908-1966

Search

Start Over Titles 4223. Misbranding of secobarbital sodium capsules and dextro-amphetamine sulfate tablets. U. S. v. Pantaze Drug Co. and Harris B. Renfroe. Pleas of nolo contendere. Fine of $50 against each defendant. ✖Remove constraint Titles: 4223. Misbranding of secobarbital sodium capsules and dextro-amphetamine sulfate tablets. U. S. v. Pantaze Drug Co. and Harris B. Renfroe. Pleas of nolo contendere. Fine of $50 against each defendant. Issue Dates November 1954 ✖Remove constraint Issue Dates: November 1954

Refine by:

  • 4223. Misbranding of secobarbital sodium capsules and dextro-amphetamine sulfate tablets. U. S. v. Pantaze Drug Co. and Harris B. Renfroe. Pleas of nolo contendere. Fine of $50 against each defendant.1